APRINOIA Therapeutics via Ross Acquisition II (ROSS) deck
APRINOIA offers patients with neurodegenerative diseases the hope of protecting their brain health and preserving their dignity through next-generation diagnostic tools and targeted therapeutics.
![](/content/images/size/w1304/2023/01/brhc10046704_ex99-2slide01-1.jpg)